The Patent Finder

Terms ending in 2044

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2044, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,758,554Stable Immediate Release Tablet and Capsule Formulations of 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,281,127Pyrido[4,3-d]pyrimidine Compounds
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 12,760,019Novel SIK Inhibitors
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,655,157SPIRO[BENZO[D]THIAZOLE-6 ,4'- Piperidine as Acc Inhibitors
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,637,461Compounds for the Activation of Ampk
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited